Group One Trading’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-43,900
Closed -$4.46M 7939
2025
Q4
$4.46M Sell
43,900
-4,300
-9% -$345K 0.01% 1608
2025
Q3
$2.64M Buy
48,200
+1,900
+4% +$94.9K ﹤0.01% 2038
2025
Q2
$2.46M Buy
46,300
+9,900
+27% +$503K 0.01% 1934
2025
Q1
$1.58M Buy
36,400
+1,900
+6% +$96.2K ﹤0.01% 2049
2024
Q4
$1.94M Buy
34,500
+2,000
+6% +$124K ﹤0.01% 1946
2024
Q3
$2.21M Sell
32,500
-30,700
-49% -$1.73M 0.01% 1638
2024
Q2
$2.67M Buy
63,200
+13,600
+27% +$748K 0.01% 1226
2024
Q1
$3.43M Buy
49,600
+21,700
+78% +$1.37M 0.01% 1098
2023
Q4
$2.06M Buy
27,900
+17,600
+171% +$1.15M 0.01% 1849
2023
Q3
$703K Sell
10,300
-25,500
-71% -$2.16M ﹤0.01% 2593
2023
Q2
$3.36M Buy
35,800
+1,400
+4% +$109K 0.01% 1276
2023
Q1
$2.33M Sell
34,400
-184,400
-84% -$11.9M 0.01% 1405
2022
Q4
$10.8M Buy
218,800
+95,400
+77% +$3.9M 0.03% 696
2022
Q3
$4.01M Sell
123,400
-118,600
-49% -$4.89M 0.01% 1335
2022
Q2
$9.53M Sell
242,000
-40,800
-14% -$2.18M 0.01% 873
2022
Q1
$19.8M Buy
282,800
+34,000
+14% +$2.49M 0.02% 624
2021
Q4
$19.4M Sell
248,800
-17,300
-7% -$1.53M 0.02% 700
2021
Q3
$25.4M Buy
266,100
+19,700
+8% +$2.08M 0.03% 515
2021
Q2
$30.6M Buy
246,400
+26,200
+12% +$3.13M 0.04% 411
2021
Q1
$29M Sell
220,200
-131,600
-37% -$18M 0.04% 389
2020
Q4
$46.6M Buy
351,800
+135,000
+62% +$16.3M 0.08% 202
2020
Q3
$22.1M Buy
216,800
+23,300
+12% +$2.01M 0.07% 244
2020
Q2
$16.8M Buy
193,500
+71,100
+58% +$5.68M 0.08% 272
2020
Q1
$7.1M Sell
122,400
-338,100
-73% -$27.4M 0.06% 378
2019
Q4
$42.6M Sell
460,500
-20,500
-4% -$1.8M 0.29% 44
2019
Q3
$43.5M Buy
481,000
+39,900
+9% +$4.55M 0.35% 32
2019
Q2
$52.1M Buy
441,100
+146,400
+50% +$14.8M 0.47% 20
2019
Q1
$25.5M Sell
294,700
-172,900
-37% -$14.7M 0.28% 46
2018
Q4
$29.5M Buy
467,600
+108,200
+30% +$7.43M 0.26% 64
2018
Q3
$28.4M Buy
359,400
+245,200
+215% +$16M 0.22% 66
2018
Q2
$6.83M Sell
114,200
-13,300
-10% -$716K 0.06% 396
2018
Q1
$5.14M Sell
127,500
-139,000
-52% -$6.78M 0.05% 453
2017
Q4
$14M Sell
266,500
-71,400
-21% -$3.81M 0.1% 234
2017
Q3
$15.9M Buy
337,900
+46,700
+16% +$1.88M 0.14% 136
2017
Q2
$10.3M Buy
291,200
+97,400
+50% +$3.01M 0.11% 209
2017
Q1
$4.58M Sell
193,800
-43,300
-18% -$858K 0.05% 440
2016
Q4
$3.17M Sell
237,100
-86,800
-27% -$1.4M 0.03% 644
2016
Q3
$6.01M Sell
323,900
-8,800
-3% -$155K 0.07% 339
2016
Q2
$4.08M Buy
332,700
+264,100
+385% +$1.99M 0.05% 469
2016
Q1
$462K Sell
68,600
-29,300
-30% -$187K 0.01% 1744
2015
Q4
$904K Sell
97,900
-19,900
-17% -$185K 0.01% 1374
2015
Q3
$2.12M Sell
117,800
-53,700
-31% -$1.23M 0.03% 749
2015
Q2
$5.1M Buy
171,500
+53,700
+46% +$1.35M 0.07% 321
2015
Q1
$2.59M Sell
117,800
-69,700
-37% -$1.77M 0.04% 517
2014
Q4
$5.14M Sell
187,500
-68,500
-27% -$1.67M 0.08% 276
2014
Q3
$4.96M Buy
256,000
+190,000
+288% +$3.48M 0.08% 296
2014
Q2
$1.12M Sell
66,000
-139,200
-68% -$1.92M 0.02% 1058
2014
Q1
$2.91M Buy
205,200
+59,200
+41% +$799K 0.05% 448
2013
Q4
$1.71M Sell
146,000
-25,600
-15% -$294K 0.03% 731
2013
Q3
$2.03M Sell
171,600
-115,900
-40% -$1.49M 0.04% 552
2013
Q2
$4M Buy
+287,500
New +$3.12M 0.1% 193

Other funds holding EXAS

Group One Trading's EXAS Position: Q3 2024 in Review

Group One Trading sold out of Exact Sciences (EXAS) in Q3 2024, closing a stake of 29,726 shares — an estimated $1.68M sold.

Group One Trading first reported a position in EXAS in Q3 2014 and held it in 28 quarters. The position peaked at $7.54M in Q2 2021. 598 funds tracked by Wall St. Rank hold EXAS as of Q3 2024.

  • Group One Trading reported no remaining Exact Sciences position as of Q3 2024 after selling out during the quarter.
  • Group One Trading sold 29,726 Exact Sciences shares in Q3 2024, an estimated $1.68M.
  • Group One Trading first reported a position in Exact Sciences in Q3 2014 and held it in 28 quarters.
  • Group One Trading's Exact Sciences position peaked at $7.54M in Q2 2021.
  • 598 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2024.

Based on Group One Trading's 13F filing for Q3 2024, filed 14 Nov 2024.